During the past decade, Harvard Eye Associates conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harvard Eye Associates" #1 sponsor was "Research Insight LLC" with 10 trials, followed by "MDbackline, LLC" with 6 trials sponsored, "ReVision Optics, Inc." with 3 trials sponsored, "Aerie Pharmaceuticals" with 2 trials sponsored and "Sight Sciences, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harvard Eye Associates" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Alcon Research" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "University of Pittsburgh" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Harvard Eye Associates" are "Cataract" (12 trials), "Dry Eye" (6 trials), "Cataract Surgery" (4 trials), "Presbyopia" (4 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Harvard Eye Associates" in a lesser frequency.

Most popular intervention types in "Harvard Eye Associates" are "Device" (14 trials), "Drug" (14 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Raindrop Near Vision Inlay" (2 trials), "Survey" (2 trials), "0.5% Omaveloxolone Ophthalmic Suspension" (1 trials), "1% Omaveloxolone Ophthalmic Suspension" (1 trials) and "Alcon PanOptix or PanOptix Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harvard Eye Associates" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Harvard Eye Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Harvard Eye Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Harvard Eye Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 9 trials that are defined as “Not Applicable".